Q3 2020 13F Holders as of 30 Sep 2020
-
Type / Class
-
Equity / Common Stock, $0.0001 par value per share
-
Shares outstanding
-
69,596,826
-
Total 13F shares
-
21,632,831
-
Share change
-
-215,192
-
Total reported value
-
$793,536,439
-
Price per share
-
$36.67
-
Number of holders
-
57
-
Value change
-
-$7,640,662
-
Number of buys
-
13
-
Number of sells
-
28
Institutional Holders of Phathom Pharmaceuticals, Inc. - Common Stock, $0.0001 par value per share (PHAT) as of Q3 2020
As of 30 Sep 2020 Phathom Pharmaceuticals, Inc. - Common Stock, $0.0001 par value per share (PHAT) had 57 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 21,632,831 shares of stock of the company.
Largest 10 holders included FRAZIER MANAGEMENT LLC, RA CAPITAL MANAGEMENT, L.P., Invesco Ltd., Medicxi Ventures Management (Jersey) Ltd, JANUS HENDERSON GROUP PLC, Abingworth LLP, Ensign Peak Advisors, Inc, VANGUARD GROUP INC, BlackRock Inc., and EVENTIDE ASSET MANAGEMENT, LLC.
This table shows 57 institutional shareholders of the security as of 30 Sep 2020.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.